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Integrin structures and conformational signaling
Bing-Hao Luo and Timothy A Springer
The CBR Institute for Biomedical Research and Departments of Pathology, Harvard Medical School,
200 Longwood Ave, Boston, MA 02115, USA
Abstract
Integrins are cell adhesion molecules that play critical roles in development, wound healing,
hemostasis, immunity and cancer. Advances in the past two years have shed light on the structural
basis for integrin regulation and signaling, especially on how global conformational changes between
bent and extended conformations relate to the inter-domain and intra-domain shape shifting that
regulates affinity for ligand. The downward movements of the C-terminal helices of the α I and β I
domains and the swing-out of the hybrid domain play pivotal roles in integrin conformational
signaling. Experiments have also shown that integrins transmit bidirectional signals across the plasma
membrane by coupling extracellular conformational change with an unclasping and separation of the
α and β transmembrane and cytoplasmic domains.
Introduction
Integrins are cell adhesion molecules that mediate cell–cell, cell–extracellular matrix and cell–
pathogen interactions. They transmit signals bidirectionally across the plasma membrane and
regulate many biological functions, including wound healing, cell differentiation and cell
migration. Integrins contain two non-covalently associated, type I transmembrane (TM)
glycoprotein α and β subunits with large extracellular domains, single-spanning TM domains
and short cytoplasmic domains (Figure 1a). The structures of the extracellular fragment of
integrin αVβ3 revealed an unexpected, compact, V-shaped conformation, with each leg bent
(Figure 1b) [1,2]. Recently, an increasing number of studies have together established that the
bent conformation represents the physiological low-affinity state, whereas priming and ligand
binding induce a large-scale conformational rearrangement in which the integrin extends with
a ‘switchblade’-like motion (Figure 1b and c) [3-5,6••]. In this review, we focus on recent
progress on how signals are communicated between the ligand binding domains and the plasma
membrane at the molecular and atomic level.
Integrin ectodomain crystal structures
The integrin β-subunits contain very sophisticated domain insertions: the β I domain is inserted
in the hybrid domain, which is in turn inserted in the PSI (for plexins, semaphorins, and
integrins) domain (Figure 1a) [6••]. These domain insertions play a critical role in integrin
signal transmission. The β I domain directly binds ligands in integrins that lack α I domains,
and indirectly regulates ligand binding by integrins that contain α I domains. The structure of
the β I domain was first solved in the context of αVβ3 extracellular domains in the absence of
ligand [1]. The β I domain is structurally homologous to integrin α subunit I domains, which
have been solved only as isolated domains, and are described in more detail below. In α I
domains, rearrangements in loops surrounding the metal-ion-dependent adhesion site
(MIDAS) increase affinity for ligand, and are linked to downward displacement of the α7-
helix. Soaking of a ligand-mimetic Arg-Gly-Asp-containing cyclic peptide into the integrin
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αVβ3 crystals revealed that the Arg binds the αV β-propeller domain and the Asp binds a metal
ion held in the MIDAS of the β3 I domain [2]. Movements of residues near the MIDAS in the
β1-α1 loop, α1-helix, and β6-α7 loop were seen that enabled ligand binding in the closed state
(Figure 2a). However, downward displacement of the α7-helix was not seen (Figure 2a), and
it was therefore suggested that the α I and the β I domains are activated by distinct mechanisms
[2]. However, subsequent mutagenesis studies [7-9,10•,11] and the structure of the αIIbβ3
headpiece co-crystallized with different ligands [6••] revealed downward α7-helix
displacement in the open, high-affinity state of the β I domain (Figure 2a), and marked structural
similarity between α I and β I domain allostery.
The β3 subunit I, hybrid, and PSI domains from the closed, low-affinity unliganded αVβ3
structure, the closed, low-affinity liganded (ligand soaked) αVβ3 structure, and the open, high-
affinity liganded (ligand co-crystallized) αIIbβ3 structure are compared in Figure 2a. The
liganded, high-affinity αIIbβ3 headpiece structure enables atomic-level understanding of the
mechanism of integrin activation [6••]. In the high-affinity, liganded β I domain compared with
the low-affinity, unliganded β I domain, there are concerted movements of the β1-α1 and β6-
α7 loops surrounding the ligand-binding pocket and of the α1 and α7 helices (Figure 2).
Coordination of the Met335 backbone carbonyl in the β6-α7 loop to the ADMIDAS (adjacent
to MIDAS) Ca2+ in the low-affinity, unliganded conformation is broken in the high-affinity,
liganded conformation. This enables the ADMIDAS metal, and residues in the β1-α1 loop that
coordinate to both the ADMIDAS and the MIDAS metals, to shift markedly, remodeling the
ligand binding site and increasing affinity for ligand. Movements of the α1-helix, β6-α7 loop
and α7-helix are tightly coupled, so that reshaping to the high-affinity ligand-binding site is
allosterically linked to downward movement of the α7-helix. This linkage is critical for
propagation of conformational signals from the ligand-binding pocket to the other integrin
domains and vice versa (Figure 2a).
The orientation between the β I and hybrid domains appears to be the critical ‘translator’
converting global conformational change into local intradomain conformational changes that
regulate affinity (Figure 2a). The piston-like displacement of the β I domain α7-helix in the
high-affinity, liganded crystal structure results in complete remodeling of the interface between
these domains, leading to the swing-out of the hybrid domain (Figure 1b, panel iii and Figure
2a) [6••]. Relative to the closed conformation, the hybrid domain swings out about 60°, causing
the knees of the α and β subunits to separate by 70 Å
Structures of the β3 and β2 integrin PSI domains and β2 I-EGF1 domain [6••,12,13•] revised
the connectivity of the previously identified long-range disulfide bond, which is now shown
to link β3 Cys-13 to Cys-435 (or β2 Cys-11 to Cys-425). The structures show that this long-
range disulfide bond occurs within the PSI domain, and therefore the hybrid domain is inserted
in the PSI domain (Figure 1a). During the rearrangement of the headpiece between the closed
and open conformations, there is no change in the hybrid/PSI domain interface. Therefore, this
rigid interface, which is reinforced by the two polypeptide chain connections, nearby disulfide
bonds and an Arg deeply buried in the interface, enables the PSI domain to amplify the leg
separation triggered by the swing-out of the hybrid domain [6••,13•] (Figure 2a). The PSI and
I-EGF1 domains are also shown to be intimately associated so that the hybrid and PSI/I-EGF1
domains move as a rigid unit [13•]. Some activating antibodies bind to the PSI domain and
induce the high affinity state [14,15].
The knee of the β subunit is located between the PSI/I-EGF1 and I-EGF2 domains; the knee
or genu of the α subunit is a small Ca2+-binding loop between the thigh and calf-1 domains.
Work using an αL antibody that reports extension and maps to the inner face of the thigh
domain, and which requires the genu and a Ca2+-coordinating residue donated by the calf-1
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domain, suggests that integrin α-subunit extension occurs by movement of the thigh–genu
linker (αV residues 594-595), a conclusion that is supported by structural inspection [16].
A large range of studies support the importance of integrin extension and hybrid-domain swing-
out in integrin activation. Perhaps most definitive are the crystal structures of four independent
examples of the αIIbβ3 head-piece, in two different crystal forms, with three different ligands
or a pseudo ligand bound, all of which reveal similar hybrid domain swing-out [6••]. The swing-
out of the hybrid domain necessitates the existence of the extended conformation, because the
hybrid domain is central in the interfaces that are buried in the bent conformation; these
interfaces are completely broken by hybrid domain swing-out [6••].
Integrin electron microscopy studies
Early electron microscopy (EM) studies revealed extended conformations. A later EM study
revealed the bent conformation and showed it had low affinity for ligand and was stabilized
by Ca2+ and close association of the α and β subunits near their junction with the membrane,
and that activation with Mn2+ or breaking the juxtamembrane clasp favored extension [3]. In
integrins on the cell surface, stabilizing the bent conformation with mutationally introduced
disulfide bonds inhibits ligand binding [3]. Both closed and open headpiece conformations,
i.e. with the hybrid domains swung in or out, respectively (Figure 1b), were seen in unclasped
and Mn2+-treated extended integrins; however, cyclic Arg-Gly-Asp not only induced extension
but also specifically stabilized the open headpiece conformation [3]. Recent studies with the
I-domain-containing integrins αLβ2 and αXβ2 reveal the same three overall conformational
states. Furthermore, Fab fragments of antibodies known to induce or report the active
conformation bind exclusively to the extended conformation, with both open and closed
headpiece conformations present, definitively establishing that extension is sufficient to
activate integrins on the cell surface, and that physiologic agonists such as chemoattractants
and agents such as phorbol myristate acetate and the talin head domain induce cell surface
integrin extension [17••]. Electron tomography of negatively stained, active detergent-soluble
αIIbβ3 purified on an Arg-Gly-Asp peptide affinity column reveals an extended conformation
with >90% of particles showing an open headpiece structure that matches perfectly [18•] the
open, liganded αIIbβ3 headpiece crystal structure [6••].
Two notable studies differ in their conclusions from those described above. Cryo-EM
reconstructions of detergent-soluble αIIbβ3 molecules revealed a conformation that is
intermediate between bent and extended conformations [19]. However, for particles the size
of integrins, cryo-EM cannot distinguish between a particle in two different orientations or two
different conformations [20]. Since preparations of integrins, including αIIbβ3, often contain
a mixture of particles with different conformations [3], the intermediate αIIbβ3 conformation
may have resulted from averaging together particles in extended and bent conformations. Other
observations support this speculation, since to fit an atomic model into the intermediate
αIIbβ3 EM density, marked changes in orientation at the β-propeller/thigh interface and calf-1/
calf-2 interface were required [19] that are inconsistent with recent EM studies [3,4,17••,18•].
A negative stain study of integrin αVβ3 in 0.2 mM Mn2+ or 0.2 mM Mn2+ with a fibronectin
fragment revealed a bent conformation [21], whereas a study of αVβ3 with 1mM Mn2+, or
cyclic Arg-Gly-Asp in the presence of either 1 mM Mn2+ or 5 mM Ca2+, revealed
predominantly extended conformations [3]. These differences might reflect the different
ligands or Mn2+ concentrations used. Another important difference is the extensive aggregation
present in the one field view shown in Adair et al. [21] but not in the eight field views shown
in Takagi et al. [3], which led Adair et al. [21] to state that, “We cannot exclude the possibility
that unsampled regions on the grid might have preferentially arisen from aggregated extended
forms.”
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It is interesting to note the differing methodologies employed in 3D reconstructions of
negatively stained integrins [20,22]. In the random conical tilt [4] and tomography studies
[18•], each particle was imaged at two or 23 different tilt angles, respectively, and 3D electron
density maps were then computed independently of any crystal structure information. The EM
density showed excellent agreement with crystal structures that were currently [4,18•] or only
subsequently [4] available. In the angular reconstitution study [21], each particle was imaged
at a single angle. Reconstruction used resolution-filtered crystal structures as starting models,
and particles were automatically selected for use in reconstruction if they were similar to 2D
projections of these models. The final models are similar to the starting atomic models, except
that in the liganded model several of the fibronectin domains are no longer present and density
for I-EGF domains 1 and 2, which was absent from the starting model, was acquired; however,
in the unliganded model, density for I-EGF domains 1 and 2 remains missing in the final model.
Other studies on ectodomain conformation
Aside from structural work [3,4,6••,17••,18•,23] integrin extension and hybrid domain swing-
out are supported by a wide range of other studies. Stabilizing the open head-piece by
mutationally introducing an N-glycosylation site into the hybrid-β I domain interface increases
ligand-binding affinity [24,25]. An allosteric β1 antibody that inhibits ligand binding has been
shown by epitope mapping and EM to restrict the swing-out of the hybrid domain [25]. The
functional properties of a β2 mAb suggest it also inhibits by blocking signal transmission at
the β I-hybrid domain interface [26]. Activation-dependent mAbs that map to the inner face
of the hybrid domain support conformational change between the β I and hybrid domains [9,
27]. Epitope exposure suggests that ligand binding and a mutation of the β I domain α7 helix
that stabilizes the high affinity state induce hybrid domain swing-out, confirming the
relationship between movement of the α7 helix and hybrid domain swing-out [9]. Integrin
extension on the cell surface was confirmed by studies using fluorescence resonance energy
transfer (FRET) between fluorescent ligand-bound integrins and lipophilic probes [28].
As an alternative or supplement to integrin extension and hybrid domain swing-out, a
‘deadbolt’ model has been proposed in which interaction at a very small 60 Å2 interface
between the β-tail domain CD loop (the dead-bolt) and the β I domain α7 helix is critical for
stabilizing integrins in the low affinity state [29]. Since hybrid domain swing-out requires β6-
α7 loop and α7-helix displacement, mutation of the β-tail domain CD loop is required to test
this model. We found that deleting β3 integrin CD loop residues 672–674 or mutating these
residues to Ala has no effect on ligand binding or activation epitope exposure by integrins
αIIbβ3 and αVβ3 (our unpublished data). Therefore, the β-tail CD loop does not function as a
deadbolt.
Integrins containing an α I domain
Compared to the integrins lacking an α I domain, conformational regulation of integrins
containing an α I domain requires the additional step of transmission of allostery from the β I
domain to the α I domain (Figure 1c). Crystal structures of α I domains reveal three distinct
conformations, namely closed, intermediate and open [30,31]. They differ not only in the
coordination of residues with the MIDAS, but in the structure of surrounding loops and in the
positions of the β6-α7 loop and α1 and α7 helices (Figure 2b). Introducing pairs of cysteines
to stabilize the β6-α7 loop in the intermediate and open conformations led to 500- and 10,000-
fold higher affinity to ICAM-1, respectively [31]. Molecular dynamic studies showed that the
intermediate conformation was on the pathway from the closed to the open conformation of
the αL and αM I domains, but not the α1 and α2 I domains [32]. The study provides strong
support for the idea that the intermediate conformation could be of physiologic importance for
fine regulation of integrin affinity.
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EM studies of αXβ2 and αLβ2 integrins reveal no activation-dependent change in α I domain
orientation relative to the β propeller domain analogous to that observed between the β I domain
and hybrid domain [17••]. This is consistent with a proposal that the α I domain α7-helix
transmits allostery between the α I MIDAS and the β I MIDAS. That is, it is proposed that in
the active state, downward movement of the α I domain α7-helix enables an invariant Glu
residue that is present a few residues after the α7-helix to act as an ‘intrinsic ligand’ and engage
the β I MIDAS [33,34•]. Yang et al. showed that individual mutation of the αL linker residue
Glu-310 or β2 MIDAS residues Ala-210 or Tyr-115 to cysteine abolishes I domain activation,
whereas the double mutations of αL-E310C with either β2-A210C or β2-Y115C form disulfide
bonds that constitutively activate ligand binding [34•]. The activation effect of the disulfide
mutant is susceptible to small molecule antagonists that bind underneath the I domain α7-helix
and certain allosteric antagonistic antibodies. This study provides direct evidence for an
activating interaction between αL residue Glu-310 and the β2 MIDAS (Figure 1c, panel iii),
and suggests that the α7-helix and its linker are better modeled as a pull spring than a bell rope
[34•].
Conformational change in integrin cytoplasmic and transmembrane domains
Recently, the basis for integrin activation across the plasma membrane has also been studied.
Separation of integrin legs results in integrin activation [5,35,36,37•], suggesting that
association of the integrin TM and cytoplasmic domains stabilizes integrins in the low affinity
state. FRET shows that in the resting state the integrin α and β subunit cytoplasmic domains
are close to one another, but undergo significant spatial separation upon inside-out activation
induced by G-protein-coupled receptors, phorbol ester or talin head domain, or upon outside-
in signaling induced by ligand binding [5]. NMR studies of the integrin cytoplasmic tails
suggest that their association is weak, with significant differences between published structures
of associated cytoplasmic domains [38•,39,40], or with association between α and β subunit
cytoplasmic domains being undetectable [41]. How the talin head domain and filamin bind to
the integrin β cytoplasmic domain and activate integrins has been revealed by NMR structures
[42-45].
Disulfide scanning of the exofacial portions of the TM domains showed a specific α-helical
interface between the α and β? TM domains in the resting state [37•]. The two TM domains
separate rather than rearrange after activation of integrins from inside the cell. Introduction of
disulfide bridges to prevent or reverse separation abolished the activating effect of cytoplasmic
mutations [37•]. Several other mutagenesis studies also suggest that a specific interface
stabilizes integrins in the resting state [46,47,48•]. Modeling of the integrin TM domain
interface, with or without experimental data, has resulted in models with different interfaces
[37•,48•,49,50]. Further experimental data and more comprehensive analysis are required.
Homomeric TM domain association following heterodimeric TM dissociation has been
proposed [51], but in subsequent studies it has been shown that this does not occur as a
consequence of integrin activation by α and β subunit TM separation, although it might occur
after binding to multivalent ligands [47,52]. Thus, numerous studies from different labs suggest
that integrin bidirectional signaling across the plasma membrane is accomplished by coupling
extracellular conformational change to an unclasping and separation of the α and β TM and
cytoplasmic domains.
Conclusions
Recent structural, biochemical and biophysical studies have greatly advanced our
understanding of the mechanisms underlying integrin bidirectional signaling across the plasma
membrane. We should always consider that integrins are in dynamic equilibrium among many
different conformational states, rather than locked in one specific state. As reviewed above,
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intracellular signals and ligand binding act by shifting the equilibrium and altering the
population of the different conformational states. It will be of great interest to use biophysical
methods to probe the dynamics of integrin signaling under physiological conditions.
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Integrin architecture and conformational changes associated with affinity regulation. (a)
Organization of domains within the primary structures. (b,c) Conformational change of
integrins lacking an I domain (b) or containing an α I domain (c). The domains are shown with
the same color scheme as in (a).
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Conformational regulation in integrin headpiece domains. (a) Overview of the movements of
the β I, hybrid, and PSI domains. Non-moving segments of the β I backbone are shown as a
grey worm. Moving segments are color-coded. The downward movement of the α7 helix is
coupled to the swing-out of the hybrid domain, which in turn plays a critical role in transmitting
signals between the ligand-binding headpiece and the integrin legs. (b) Conformational change
of the α I domain. Non-moving segments of the backbone are shown as a grey worm. The
moving segments, shown as Cα-traces, of the closed (gold) and open (cyan) αM I domains and
their MIDAS metal ions are shown, and direction of movement is shown with arrows. The
downward movement of the α7 helix plays a critical role in transmitting signals between the
α I domain and the β I domain.
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